Evaluation of Revumenib in Participants With Colorectal Cancer and Other Solid Tumors

Clinical trial NCT05731947 · TERMINATED

Trial details

NCT number: NCT05731947
Sponsor: Syndax Pharmaceuticals
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer Solid Tumors

Start date: 2023-04-04
Primary completion: 2025-06-30
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.